Goldman Sachs’s Entero Therapeutics ENTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-2
Closed -$6K 5687
2022
Q2
$6K Buy
+2
New +$6K ﹤0.01% 5572
2021
Q3
Sell
-1
Closed -$68K 5560
2021
Q2
$68K Buy
+1
New +$68K ﹤0.01% 5207
2017
Q4
Hold
0
-$43K 4324
2017
Q3
Hold
0
4134